Stock comparison
Novartis AG is 73.8x more valuable than Telix Pharmaceuticals Ltd by market capitalization ($294.66 B vs $3.99 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
NVS is larger
Novartis AG is 73.8x more valuable than Telix Pharmaceuticals Ltd by market capitalization ($294.66 B vs $3.99 B).
Market value leader
NVS
Novartis AG is 73.8x more valuable than Telix Pharmaceuticals Ltd by market capitalization ($294.66 B vs $3.99 B).
| Metric | TLX | NVS |
|---|---|---|
| Market cap | $3.99 B | $294.66 B |
| US-listed rank | #1609 | #46 |
| Net margin | - | - |
| P/E (trailing FY) | - | - |
| SEC filings | 95 | 981 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
Novartis AG is 73.8x more valuable than Telix Pharmaceuticals Ltd by market capitalization ($294.66 B vs $3.99 B).
Full pages: Telix Pharmaceuticals Ltd and Novartis AG, or browse the full rankings.